0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover514.95%IV-459.91%PremiumJan 17, 2025Expiry Date4.11Intrinsic Value100Multiplier23DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.7523Delta0.2801Gamma0.21Leverage Ratio-0.0075Theta-0.0020Rho-0.16Eff Leverage0.0007Vega
Cytosorbents Stock Discussion
CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India
CytoSorbents (NASDAQ: CTSO) and Converge Biotech have announced a strategic partnership to expand their market reach in India's sepsis and critical care markets. CytoSorbents' flagship product, CytoSorb, a blood purification technology that reduces cytokine storm and inflammatory toxins, will be distributed through Converge Biotech's ext...
📊⚡️📊
NEWS
CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe
No comment yet